Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- S +16.5%, PHR +14.6%, OLLI +8.2%, KFY +6.6%, SFIX +4.1%, POWL +2.8%, TOL +1.9%, CPB +1.6%, THO +1%
Other news:
- PHVS +96.6% (announces positive top-line phase 2 data from the chapter-1 study of Deucrictibant for the prophylactic treatment of HAE attacks; announces pricing of offering of 11.125 mln shares of common stock at price of $24/share)
- ASPN +15% (announces award for its PyroThin EV segment; provides update on its DoE loan)
- EYPT +5.7% (prices offering of 11764706 shares of its common stock at $17.00 per share)
- CHRS +4.5% (Presents Phase 1/2 Clinical Data on Casdozokitug a First-in-Class IL-27-Targeted Antibody at the 2023 ESMO Immuno-Oncology Congress)
- CAR +4.5% (declares special dividend of $10.00 per share)
- RCM +3.5% (announced that it has entered into a definitive agreement to acquire Acclara)
- RYTM +3.2% (Announces Updates on MC4R Pathway Programs at R&D Event)
- ATAT +3% (prices secondary offering of 9.6 mln shares of common stock at $15.80 per share)
- NBIX +2.8% (FDA approves Breakthrough Therapy Designation for Crinecerfont)
- SPHR +2.5% (announces pricing of $225 million offering of convertible senior notes)
- BTBT +2.1% reports monthly production update for November)
- RIO +2% (updates progress in its portfolio for the future)
- IGMS +2% (announces strategic pipeline prioritization; to cut its workforce by 22% extends cash runway into 2Q26)
- STRL +1.8% (authorizes new $200 mln share repurchase program)
- NTB +1.7% (authorizes new $90 mln share repurchase program)
- IREN +1.6% (announces monthly investor update for November 2023; Bitcoin mined of 369)
- SIG +1.5% (files mixed shelf securities offering) EU +1.5% (enters $70 mln transaction with Boss Energy)
- RLGT +1.3% (authorizes new 5 mln share repurchase program)
- MSBI +1.1% (authorizes new $25 mln share repurchase program)
- NVAX +1.1% (updated COVID-19 vaccine now authorized in Canada)
Analyst comments:
- BLDR +3.8% (upgraded to Buy from Neutral at B. Riley Securities)
- COF +1.8% (upgraded to Buy from Neutral at BofA Securities)
- DFS +1.7% (upgraded to Buy from Neutral at BofA Securities)